Enzyme-DNA biocolloids for DNA adduct and reactive metabolite detection by chromatography-mass spectrometry

Analytical Chemistry

Volumn 80, Issue 4, 2008, Pages 922-932

  Bajrami, Besnik ^a   Hvastkovs, Eli G ^a   Jensen, Gary C ^a   Schenkman, John B ^b   Rusling, James F ^a,b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOTOXICITY; MACROSCOPIC SURFACES;

BIOREACTORS; CYTOTOXICITY; DNA; ENZYMES; MASS SPECTROMETRY; METABOLITES; SILICA;

COLLOIDS;

(4 METHYLNITROSOAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 2 BUTANONE; CYTOCHROME P450 2E1; DNA; ENZYME; GUAIACOL; LIVER ENZYME; MYOGLOBIN; NITROSAMINE; PYRIDINE DERIVATIVE; SILICON DIOXIDE; STYRENE; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; BIOREACTOR; CAPILLARY CHROMATOGRAPHY; CHROMATOGRAPHY; COLLOID; DNA ADDUCT; ELECTRICITY; FILM; GAS CHROMATOGRAPHY; GENOTOXICITY; HYDROLYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEASUREMENT; METABOLITE; NONHUMAN; OXIDATION; REACTION TIME; THERMAL ANALYSIS; TURNOVER TIME;

CAMPHOR 5-MONOOXYGENASE; CATALYSIS; CHROMATOGRAPHY, LIQUID; CYTOCHROME P-450 CYP2E1; DNA; DNA ADDUCTS; ELECTROSTATICS; EPOXY COMPOUNDS; HUMANS; LIVER; MASS SPECTROMETRY; MYOGLOBIN; TIME FACTORS;

EID: 39449085286     PISSN: 00032700     EISSN: None     Source Type: Journal    
DOI: 10.1021/ac702025f     Document Type: Article

References (71)

1. Rawlins, M. D. Nat. Rev. Cancer 2004, 3, 360-364.
2. Caldwell, G. W.; Yan, L. Curr. Opin. Drug Discovery Dev. 2006, 9, 47-50.
3. Nassar, A. E.; Kamel, A. M.; Clarimont, C. Drug Discovery Today 2004, 9, 1055-1064.
4. Guengerich, F. P. Am. Assoc. Pharm. Sci. J. 2006, 8, E101-E111.
5. Newton, R. K.; Aardema, M.; Aubrecht, J. Environ. Health Perspect. 2004, 112, 420-422.
6. Kirkland, D.; Aardema, M.; Henderson, L.; Muller, L. Mutat. Res. 2005, 584, 1-256.
7. Mayne, J. T.; Kum, W. W.; Kennedy, S. P. Curr. Opin. Drug Discovery Dev. 2006, 9, 75-83.
8. Singer, B.; Grunberger, D. Molecular Biology of Mutagens and Carcinogens; Plenum Press: New York, 1983.
9. Jacoby, W. B., Ed. Enzymatic Basis of Detoxification; Academic: New York, 1980; Vols. I and II.
10. Friedberg, E. C. Nature 2003, 421, 436-440.
11. (a) Schenkman, J. B., Greim, H., Eds. Cytochrome P450; Springer-Verlag: Berlin, 1993.
12. (b) Ortiz de Montellano, P. R., Ed. Cytochrome P450; Plenum: New York, 1995.
13. (c) Singer, B.; Grundberger, D. Molecular Biology of Mutagens and Carcinogens; Plenum: New York, 1983.
14. Scharer, O. D. Angew. Chem., Int. Ed. 2003, 42, 2946-2974.
15. (a) Farmer, P. B. Toxicol. Lett. 2004, 149, 3-9.
16. (b) Sharma, R. A.; Farmer, P. B. Clin. Cancer Res. 2004, 10, 4901-4912.
17. (c) Baird, W. M.; Mahadeva, B. Mutat. Res. 2004, 547, 1-4.
18. Hemminki, K.; Koskinen, M.; Rajaniemi, H.; Zhao, C. Regul. Toxicol. Pharmacol. 2002, 32, 264-275.
19. Appruzzese, W. A.; Vouros, P. J. Chromatogr., B 1999, 794, 97-108.
20. Vanhoutte, K.; Dongen, W.; Hoes, I.; Lemiere, F.; Esmans, E. L.; Van Onckelen, H.; Van den Eckhout, E.; Soest, R. E. J.; Hudson, A. J. Anal. Chem. 1997, 69, 3161-3168.
21. Gangl, E. T.; Turesky, R. J.; Vouros, P. Anal. Chem. 2001, 73, 2397-2404.
22. Rusling, J. F.; Hvastkovs, E. G.; Schenkman, J. B. Curr. Opin. Drug Discovery Dev. 2007, 10, 67-73.
23. Zhou, L.; Yang, J.; Estavillo, C.; Stuart, J. D.; Schenkman, J. B.; Rusling, J. F. J. Am. Chem. Soc. 2003, 125, 1431-1436.
24. Wang, B.; Jansson, I.; Schenkman, J. B.; Rusling, J. F. Anal. Chem. 2005, 77, 1361-1367.
25. Hvastkovs, E. G.; So, M.; Krishnan, S.; Bajrami, B.; Tarun, M.; Jansson, I.; Schenkman, J. B.; Rusling, J. F. Anal. Chem. 2007, 79, 1897-1906.
26. Tarun, M.; Rusling, J. F. Crit. Rev. Eukaryotic Gene Expression 2005, 15, 295-315.
27. Tarun, M.; Bajrami, B.; Rusling, J. F. Anal. Chem. 2006, 78, 624-627.
28. (a) Lvov, Y.; Caruso, F. Anal. Chem. 2001, 73, 4212-4217.
29. (b) Shutava, T.; Zheng, Z.; John, V.; Lvov, Y. Biomacromolecules 2004, 5, 914-921.
30. (c) Caruso, F.; Möhwald, H. J. Am. Chem. Soc. 1999, 121, 6039-6046.
31. (d) Fang, M.; Grant, S. P.; McShane, M. J.; Sukhorukov, G. B.; Golub, V. O.; Lvov, M. Y. Langmuir 2002, 18, 6336-6344.
32. (e) Caruso, F.; Schüler, C. Langmuir 2000, 16, 9595-9603.
33. (f) Caruso, F.; Lichtenfeld, H.; Giersig, M.; Möhwald, H. J. Am. Chem. Soc. 1998, 120, 8523-8524.
34. Lvov, Y. In Protein Architecture: Interfacing Molecular Assemblies and Immobilization Biotechnology; Lvov Y., Möhwald, H., Eds.; Marcel Dekker: New York, 2000; pp 125-167.
35. Lvov, Y. In Handbook of Surfaces And Interfaces of Materials Vol. 3. Nanostructured Materials, Micelles and Colloids; Nalwa, R. W., Ed.; Academic Press: San Diego, CA, 2001; pp 170-189.
36. Ariga, K.; Hill, J. P.; Ji, Q. Phys. Chem. Chem. Phys. 2007, 9, 2319-2340.
37. Zhang, X.; Chen, H.; Zhang, H. Chem. Commun. 2007, 1395-1405.
38. Krishnan, S.; Hvastkovs, E. G.; Bajrami, B.; Jansson, I.; Schenkman, J. B.; Rusling, J. F. Chem. Commun. 2007, 1713-1715.
39. (a) Guengerich, F. P. Chem. Res. Toxicol. 2001, 14, 611-650.
40. (b) Cirino, P. C.; Arnold, F. H. Angew. Chem., Int. Ed. 2003, 42, 3299-3301.
41. (c) Ortiz de Montellano, P. R.; Catalano, C. E. J. Biol. Chem. 1985, 260, 9265-9271.
42. Hecht, S. S. Chem. Res. Toxicol. 1998, 11, 559-603.
43. (a) Adams, C.; Adams, P. A. J. Inorg. Biochem. 1992, 45, 47-52.
44. (b) Rahimtula, A. D.; O'Brien, P. J.; Seifried, H. E.; Jerina, D. M. Eur. J. Biochem. 1978, 89, 133-141.
45. (c) Werringloer, J.; Kawano, S.; Estabrook, R. W. In Microsomes Drug Oxidations, and Chemical Carcinogenesis; Coon, M. C., Estabrook, R. W., Gelboin, H. V., Eds.; Academic Press: New York, 1980; pp 403-406.
46. (d) White, R. E.; Sligar, S. G.; Coon, M. W. J. Biol. Chem. 1980, 255, 11108-11111.
47. (a) Bichara, N.; Ching, M. S.; Blake, C. L.; Ghabrial, H.; Smallwood, R. A. Drug Metab. Dispos. 1996, 24, 112-118.
48. (b) Kupfer, R.; Liu, S. Y.; Allentoff, A. J.; Thompson, J. A. Biochemistry 2001, 40, 11490-11501.
49. Estavillo, C.; Lu, Z.; Jansson, I.; Schenkman, J. B.; Rusling, J. F. Biophys. Chem. 2003, 104, 291-296.
50. Nassar, A.-E. F.; Willis, W. S.; Rusling, J. F. Anal. Chem. 1995, 67, 2386-2392.
51. Gillam, E. M. J.; Guo, Z. Y.; Guengerich, F. P. Arch. Biochem. Biophys. 1994, 312, 59-66.
52. O'Keefe, D. H.; Ebel, R. E.; Petersen, J. A. Methods Enzymol. 1978, 52, 151-157.
53. Omura, T.; Sato, R. J. Biol. Chem. 1964, 239, 2379-2385.
54. Maehly, A.; Chance, B. Methods Biochem. Anal. 1954, 1, 357.
55. Adam, W.; Lazarus, M.; Saha-Möller, C. R.; Weichold, O.; Hoch, U.; Häring, D.; Schreier, P. Adv. Biochem. Eng. Biotechnol. 1999, 63, 73-108.
56. Doerge, D. R.; Divi, R. L.; Churchwell, M. I. Anal. Biochem. 1997, 250, 10-17.
57. Gao, J.; Rusling, J. F.; Zhou, D. J. Org. Chem. 1996, 61, 5972-5977.
58. Tarun, M.; Rusling, J. F. Anal. Chem. 2005, 77, 2056-2062.
59. Schenkman, J. B.; Jansson, I.; Lvov, Y.; Rusling, J. F.; Boussad, S.; Tao, N. J. Arch. Biochem. Biophys. 2001, 385, 78-87.
60. Ueberfeld, J.; El-Difrawy, S. A.; Ramdhanie, K.; Ehrlich, D. J. Anal. Chem. 2006, 78, 3632-3637.
61. (a) Lvov, Y. M.; Lu, Z.; Schenkman, J. B.; Zu, X.; Rusling, J. F. J. Am. Chem. Soc. 1998, 120, 4073-4080.
62. (b) Zu, X.; Lu, Z.; Zhang, Z.; Schenkman, J. B.; Rusling, J. F. Langmuir 1999, 15, 7372-7377.
63. Munge, B.; Estavillo, C.; Schenkman, J. B.; Rusling, J. F. Chem. Biochem. 2002, 4, 101-108.
64. Tanaka, E.; Terada, M.; Misawa, S. J. Clin. Pharm. Ther. 2000, 3, 165-175.
65. Wang, M.; Cheng, G.; Sturla, S. J.; Shi, Y.; McIntee, E. J.; Villalta, P. W.; Upadhyaya, P.; Hecht, S. S. Chem. Res. Toxicol. 2003, 16, 616-626.
66. Hecht, S. S. Nat. Rev. Cancer 2003, 10, 733-744.
67. Sturla, S. J.; Scott, J.; Lao, Y.; Hecht, S. S.; Villalta, P. W. Chem. Res. Toxicol. 2005, 18, 1048-1055.
68. Gonzalez, F. J. Drug Metab. Dispos. 2006, 35, 1-8.
69. Abdel-Rahman, S. Z.; Salama, S. A.; Au, W. W.; Hamada, F. A. Pharmacogenetics 2000, 10, 239-249.
70. Crespi, C. L.; Penman, B. W.; Gelboin, H. W.; Gonzalez, F. J. Carcinogenesis 1999, 12, 1197-1201.
71. Koskinen, M.; Vodicka, P.; Hemminki, K. Chem. - Biol. Interact. 2000, 124, 13-17.